Stock ALTIMMUNE INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Altimmune Inc Nyse

Equities

US71714G1022

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Altimmune Inc
07-01 Altimmune, Inc.(NasdaqGM:ALT) added to Russell 3000 Growth Index CI
07-01 Altimmune, Inc.(NasdaqGM:ALT) added to Russell Microcap Growth Index CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
BU
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
PR
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
PR
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR
Altimmune to Participate at Leerink Partners Therapeutics Forum
AQ
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
PR
ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
PR
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
ALT DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important July 5 Deadline in Securities Class Action - ALT
NE
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
PR
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt
AQ
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT)
PR
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PR
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
NE
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
AQ
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
AQ
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. Stock
  5. News Altimmune Inc
  6. Press Releases